Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high on Wednesday . The company traded as high as $1.44 and last traded at $1.40, with a volume of 9512 shares traded. The stock had previously closed at $1.39.
BioRestorative Therapies Price Performance
The firm has a market capitalization of $2.37 billion, a P/E ratio of -1.35 and a beta of 102.36. The firm has a 50-day moving average price of $1.63 and a two-hundred day moving average price of $1.59.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Tesla Investors Continue to Profit From the Trump Trade
- What Are Dividend Contenders? Investing in Dividend Contenders
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
